Pfizer
Pfizer sells Irish manufacturing facility to BioMarin
June 27, 2011Manufacturing and Production BioMarin, Ireland, Pfizer, pharma manufacturing news
Pfizer is selling its Irish manufacturing facility in Shanbally, Cork, to US biopharmaceutical company BioMarin for $48.5 million, creating up …
Pfizer to retain 350 jobs at Sandwich
June 24, 2011Research and Development Pfizer, Sandwich, pharma jobs, recruitment
Pfizer has made the surprise decision to retain 350 jobs at its research and development site in Sandwich, Kent, providing …
FDA approves Pfizer pain drug Oxecta
June 21, 2011Sales and Marketing FDA, Oxecta, Pfizer, chronic pain
The FDA has approved Pfizer and Acura’s novel pain drug Oxecta, but will require follow up studies to prove its …
Pfizer’s Sandwich site on market as ‘discovery park’
June 14, 2011Research and Development Pfizer, Sandwich, UK pharma
Pfizer has expanded its options for its main European research site, earmarked for closure in Feburary, and is now marketing …
Digital Pharma: Pfizer’s mobile-powered ‘virtual’ clinical trial
June 8, 2011Research and Development Digital Pharma blog, Pfizer, clinical trials
In an industry first Pfizer is to use mobile phone and web-based technology to collect study data for pharma’s first …
Pfizer files new kidney cancer drug
June 2, 2011Sales and Marketing Nexavar, Pfizer, rcc
Pfizer has filed its kidney cancer drug axitinib in the EU after impressive head-head- trials with Bayer’s Nexavar. Pfizer is …
Pfizer simplifies contract research with Parexel and Icon
May 27, 2011Research and Development ICON, Parexel, Pfizer, cros
Parexel and Icon have been chosen as Pfizer’s two long-term partners, in a move by the US pharma company to …
Pfizer will invest $21m in US injectables upgrade
May 25, 2011Manufacturing and Production APIs, Pfizer, pharma manufacturing
Pfizer has announced another upgrade of its sterile injectables plant in Portage, Michigan, earmarking around $21 million for new air …
Pfizer and BMS to give Eliquis a rolling launch in Europe
May 24, 2011Sales and Marketing Eliquis, Pfizer, apixaban, atrial fibrillation
Pfizer and Bristol-Myers Squibb are gearing up to give their new oral anticoagulant Eliquis a rolling launch in Europe, starting …
Pfizer and BMS’ blood thinner Eliquis approved in Europe
May 23, 2011Sales and Marketing BMS, Eliquis, Pfizer, apixaban
Pfizer and Bristol-Myers Squibb’s eagerly anticipated blood thinner Eliquis has gained European approval. A twice-daily oral Factor Xa inhibitor, Eliquis …
Digital Pharma: Pfizer scores with football game
May 20, 2011Medical Communications Back In Play, Digital Pharma blog, ManMOT, Pfizer, digi game
Pfizer’s football-themed campaign to raise awareness of ankylosing spondylitis has picked up one of a brace of awards for the …
Pfizer’s cancer drug meets end points in head-to-head study
May 20, 2011Research and Development, Sales and Marketing Pfizer, axitinib, rcc
Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …
Pfizer files lung cancer drug in US and Japan
May 18, 2011Sales and Marketing NSCLC, Pfizer, crizotinib
Pfizer has submitted its oral lung cancer drug crizotinib for regulatory approval in the US and Japan. Crizotinib is an …
Pfizer drops early-stage asthma candidate
May 11, 2011Research and Development Pfizer, Rigel, asthma
Pfizer has returned the rights to a phase I asthma candidate to Rigel Pharmaceuticals. San Francisco-based Rigel says Pfizer is …
Pfizer’s Revatio extends Europe PAH licence
May 9, 2011Sales and Marketing PAH, Pfizer, pulmonary arterial hypertension, revatio
Pfizer’s Revatio has been approved by European regulators for the treatment of pulmonary arterial hypertension (PAH) in children.The European Commission has …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
